• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测Δ-9-四氢大麻酚引起的精神活性和认知效应:一种用于量化兴奋感和警觉性降低的PBPK-PD方法。

Predicting Δ-9-Tetrahydrocannabinol-Induced Psychoactive and Cognitive Effects: A PBPK-PD Approach to Quantifying Feeling High and Reduced Alertness.

作者信息

Qian Lixuan, Zhou Zhu

机构信息

Department of Chemistry, York College, City University of New York, Jamaica, New York 11451, United States.

出版信息

ACS Chem Neurosci. 2025 Aug 6;16(15):3059-3069. doi: 10.1021/acschemneuro.5c00417. Epub 2025 Jul 22.

DOI:10.1021/acschemneuro.5c00417
PMID:40694686
Abstract

The increasing use of cannabis for medicinal and recreational purposes highlights the need to understand its psychoactive effects. Δ-9-tetrahydrocannabinol (THC), the primary psychoactive cannabinoid, is responsible for feeling high and reduced alertness after cannabis use. This study aimed to develop and verify physiologically based pharmacokinetic-pharmacodynamic (PBPK-PD) models to quantify the effects of THC and its active metabolite, 11-hydroxy-THC, on feeling high and reduction in alertness in healthy adults. The models were developed using Simcyp, based on our previously verified THC PBPK model. A direct response model with a maximum effect () function driven by the brain concentrations and an effect compartment was used to describe visual analogue scale (VAS) scores for feeling high after intravenous, oral, and inhaled THC administration. An indirect response model with an function driven by the brain concentrations was used to describe the reduction in VAS alertness scores after inhaled THC. Our models accurately captured the dose-response relationships for THC doses ranging from 2 to 86 mg for feeling high, and 2 to 69.4 mg for alertness reduction. The verified PBPK-PD model provides a robust tool for predicting the psychoactive and cognitive effects of THC, enabling improved assessment of cannabis-induced responses across diverse populations.

摘要

大麻在医疗和娱乐用途上的使用日益增加,这凸显了了解其精神活性作用的必要性。Δ-9-四氢大麻酚(THC)是主要的精神活性大麻素,会导致使用大麻后产生兴奋感并降低警觉性。本研究旨在开发并验证基于生理学的药代动力学-药效学(PBPK-PD)模型,以量化THC及其活性代谢物11-羟基-THC对健康成年人兴奋感和警觉性降低的影响。这些模型是基于我们之前验证过的THC PBPK模型,使用Simcyp开发的。一个由脑内浓度和效应室驱动的具有最大效应()函数的直接反应模型,用于描述静脉注射、口服和吸入THC后兴奋感的视觉模拟量表(VAS)评分。一个由脑内浓度驱动的具有函数的间接反应模型,用于描述吸入THC后VAS警觉性评分的降低。我们的模型准确地捕捉了2至86毫克THC剂量产生兴奋感以及2至69.4毫克THC剂量降低警觉性的剂量反应关系。经过验证的PBPK-PD模型为预测THC的精神活性和认知作用提供了一个强大的工具,有助于更好地评估不同人群中大麻引起的反应。

相似文献

1
Predicting Δ-9-Tetrahydrocannabinol-Induced Psychoactive and Cognitive Effects: A PBPK-PD Approach to Quantifying Feeling High and Reduced Alertness.预测Δ-9-四氢大麻酚引起的精神活性和认知效应:一种用于量化兴奋感和警觉性降低的PBPK-PD方法。
ACS Chem Neurosci. 2025 Aug 6;16(15):3059-3069. doi: 10.1021/acschemneuro.5c00417. Epub 2025 Jul 22.
2
The Pharmacokinetics and Pharmacodynamics of a Hemp-Derived "Full-Spectrum" Oral Cannabinoid Product with a 1:1 Ratio of Cannabidiol to Cannabidiolic Acid and Delta-9-Tetrahydrocannabinol to Delta-9-Tetrahydrocannabinolic Acid: A Double-Blind, Placebo-Controlled, Within-Subjects Human Laboratory Study.一种大麻衍生的“全谱”口服大麻素产品的药代动力学和药效学,该产品中大麻二酚与大麻二酚酸以及Δ9-四氢大麻酚与Δ9-四氢大麻酚酸的比例为1:1:一项双盲、安慰剂对照、受试者内人体实验室研究。
Cannabis Cannabinoid Res. 2025 Apr;10(2):e299-e313. doi: 10.1089/can.2024.0187. Epub 2025 Mar 5.
3
A within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults.一项比较口服δ-8-四氢大麻酚和δ-9-四氢大麻酚对健康成年人急性影响的受试者内交叉试验。
Drug Alcohol Depend. 2025 Jul 1;272:112676. doi: 10.1016/j.drugalcdep.2025.112676. Epub 2025 Apr 12.
4
The Individual and Interactive Effects of Alpha-Pinene and Delta-9-Tetrahydrocannabinol in Healthy Adults.α-蒎烯和Δ-9-四氢大麻酚对健康成年人的个体及交互作用
Med Cannabis Cannabinoids. 2025 Jun 25;8(1):144-157. doi: 10.1159/000547014. eCollection 2025 Jan-Dec.
5
A within-subject cross-over trial comparing the acute effects of vaporized delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults.一项在健康成年人中比较汽化δ-8-四氢大麻酚和δ-9-四氢大麻酚急性效应的受试者内交叉试验。
Drug Alcohol Depend. 2025 Jul 1;272:112684. doi: 10.1016/j.drugalcdep.2025.112684. Epub 2025 Apr 21.
6
The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.大麻在医学上用于降低艾滋病毒/艾滋病患者的发病率和死亡率。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD005175. doi: 10.1002/14651858.CD005175.pub3.
7
Cannabidiol interactions with Δ-9-tetrahydrocannabinol on antinociception after carrageenan-induced inflammatory pain in male and female rats.大麻二酚与Δ-9-四氢大麻酚对角叉菜胶诱导的雄性和雌性大鼠炎性疼痛后抗伤害感受的相互作用。
J Pharmacol Exp Ther. 2025 Jul;392(7):103625. doi: 10.1016/j.jpet.2025.103625. Epub 2025 Jun 11.
8
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
9
Beneficial and adverse effects of THC on cognition in the HIV-1 transgenic rat model: Importance of exploring task- and sex-dependent outcomes.四氢大麻酚对HIV-1转基因大鼠模型认知的有益和不良影响:探索任务和性别依赖性结果的重要性。
Brain Behav Immun. 2025 Apr 24;128:571-588. doi: 10.1016/j.bbi.2025.04.030.
10
Examining the Systemic Bioavailability of Cannabidiol and Tetrahydrocannabinol from a Novel Transdermal Delivery System in Healthy Adults: A Single-Arm, Open-Label, Exploratory Study.在健康成年人中检查新型经皮给药系统中大麻二酚和四氢大麻酚的系统生物利用度:一项单臂、开放标签、探索性研究。
Adv Ther. 2023 Jan;40(1):282-293. doi: 10.1007/s12325-022-02345-5. Epub 2022 Oct 29.

本文引用的文献

1
Quantifying Heart Rate Changes After Delta-9-Tetrahydrocannabinol Administration Using a PBPK-PD Model in Healthy Adults.使用PBPK-PD模型对健康成年人服用Δ-9-四氢大麻酚后的心率变化进行量化。
Pharmaceutics. 2025 Feb 12;17(2):237. doi: 10.3390/pharmaceutics17020237.
2
Physiologically Based Pharmacokinetic Modeling of Cannabidiol, Delta-9-Tetrahydrocannabinol, and Their Metabolites in Healthy Adults After Administration by Multiple Routes.健康成年人经多种途径给药后,大麻二酚、Δ⁹-四氢大麻酚及其代谢物的基于生理的药代动力学建模
Clin Transl Sci. 2025 Jan;18(1):e70119. doi: 10.1111/cts.70119.
3
A 10-year trend in cannabis potency (2013-2022) in different geographical regions of the United States of America.
美国不同地理区域大麻效力的 10 年趋势(2013-2022 年)。
Front Public Health. 2024 Oct 3;12:1442522. doi: 10.3389/fpubh.2024.1442522. eCollection 2024.
4
Event-level associations among THC, CBD, social context, and subjective effects during Cannabis use episodes.在大麻使用期间,大麻素 THC、大麻二酚 CBD、社会环境和主观效应之间的事件级关联。
J Psychopharmacol. 2024 Nov;38(11):961-971. doi: 10.1177/02698811241269800. Epub 2024 Aug 16.
5
A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator.用于 Simcyp 模拟器中基于生理的药代动力学建模的群体文件开发指南。
CPT Pharmacometrics Syst Pharmacol. 2024 Sep;13(9):1429-1447. doi: 10.1002/psp4.13202. Epub 2024 Jul 18.
6
CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions.特殊人群中的大麻二酚(CBD)和四氢大麻酚(THC):药代动力学与药物相互作用
Pharmaceutics. 2024 Apr 1;16(4):484. doi: 10.3390/pharmaceutics16040484.
7
Serotonergic modulation of vigilance states in zebrafish and mice.在斑马鱼和小鼠中对警觉状态的血清素调制。
Nat Commun. 2024 Mar 22;15(1):2596. doi: 10.1038/s41467-024-47021-0.
8
Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from (Henola Variety) Inflorescences.具有增溶载体的共分散递送系统改善大麻(赫诺拉品种)花序中大麻素(大麻二酚、大麻二酚酸和大麻色烯)的溶解度和渗透性。
Pharmaceutics. 2023 Sep 4;15(9):2280. doi: 10.3390/pharmaceutics15092280.
9
Understanding feeling "high" and its role in medical cannabis patient outcomes.了解“兴奋”的感觉及其在医用大麻患者治疗结果中的作用。
Front Pharmacol. 2023 May 24;14:1135453. doi: 10.3389/fphar.2023.1135453. eCollection 2023.
10
Use of the visual analogue scale for health state valuation: a scoping review.使用视觉模拟量表评估健康状况:范围综述。
Qual Life Res. 2023 Oct;32(10):2719-2729. doi: 10.1007/s11136-023-03411-3. Epub 2023 Apr 7.